0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Dry Powder Inhaler Device Market Research Report 2026
Published Date: 2026-02-05
|
Report Code: QYRE-Auto-1J368
Home | Market Reports | Health| Medical Devices & Equipment
Global Dry Powder Inhaler Device Market Insights and Forecast to 2028
BUY CHAPTERS

Global Dry Powder Inhaler Device Market Research Report 2026

Code: QYRE-Auto-1J368
Report
2026-02-05
Pages:120
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Dry Powder Inhaler Device Market Size

The global Dry Powder Inhaler Device market was valued at US$ 903 million in 2025 and is anticipated to reach US$ 1256 million by 2032, at a CAGR of 4.9% from 2026 to 2032.

Dry Powder Inhaler Device Market

Dry Powder Inhaler Device Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Dry Powder Inhaler Device competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
A dry powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of diabetes mellitus.
GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, etc. are the key players in the global Dry Powder Inhaler Device market. Top 4 took up more than 30% of the global market.
From the view of region, USA have a larger consumption market share which account for about 35% of total share. Europe hold a market share of about 25%. In addition, Asia Pacific is also play important role in Global market.
Dry Powder Inhaler Device main application area is Asthma This sector hold a market share of over 80%. Then followed by the COPD.
According to the Segmentation of types, all the market of Dry Powder Inhaler Device can be divided as follows: Multi-dose, Single-dose.
This report delivers a comprehensive overview of the global Dry Powder Inhaler Device market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Dry Powder Inhaler Device. The Dry Powder Inhaler Device market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Dry Powder Inhaler Device market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Dry Powder Inhaler Device manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Dry Powder Inhaler Device Market Report

Report Metric Details
Report Name Dry Powder Inhaler Device Market
Accounted market size in 2025 US$ 903 million
Forecasted market size in 2032 US$ 1256 million
CAGR 4.9%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Single Dose
  • Multi Dose
by Application
  • Asthma
  • COPD
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, 3M, Hovione, Mannkind, Mylan, Novartis, Schering/Merck, Teva, Vectura
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Dry Powder Inhaler Device manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Dry Powder Inhaler Device sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Dry Powder Inhaler Device Market growing?

Ans: The Dry Powder Inhaler Device Market witnessing a CAGR of 4.9% during the forecast period 2026-2032.

What is the Dry Powder Inhaler Device Market size in 2032?

Ans: The Dry Powder Inhaler Device Market size in 2032 will be US$ 1256 million.

What is the Dry Powder Inhaler Device Market share by region?

Ans: From the view of region, USA have a larger consumption market share which account for about 35% of total share. Europe hold a market share of about 25%.

What is the Dry Powder Inhaler Device Market share by application?

Ans: Dry Powder Inhaler Device main application area is Asthma This sector hold a market share of over 80%.

Who are the main players in the Dry Powder Inhaler Device Market report?

Ans: The main players in the Dry Powder Inhaler Device Market are GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, 3M, Hovione, Mannkind, Mylan, Novartis, Schering/Merck, Teva, Vectura

What are the Application segmentation covered in the Dry Powder Inhaler Device Market report?

Ans: The Applications covered in the Dry Powder Inhaler Device Market report are Asthma, COPD, Others

What are the Type segmentation covered in the Dry Powder Inhaler Device Market report?

Ans: The Types covered in the Dry Powder Inhaler Device Market report are Single Dose, Multi Dose

1 Dry Powder Inhaler Device Market Overview
1.1 Product Definition
1.2 Dry Powder Inhaler Device by Type
1.2.1 Global Dry Powder Inhaler Device Market Value by Type: 2025 vs 2032
1.2.2 Single Dose
1.2.3 Multi Dose
1.3 Dry Powder Inhaler Device by Application
1.3.1 Global Dry Powder Inhaler Device Market Value by Application: 2025 vs 2032
1.3.2 Asthma
1.3.3 COPD
1.3.4 Others
1.4 Global Dry Powder Inhaler Device Market Size Estimates and Forecasts
1.4.1 Global Dry Powder Inhaler Device Revenue 2021–2032
1.4.2 Global Dry Powder Inhaler Device Sales 2021–2032
1.4.3 Global Dry Powder Inhaler Device Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Dry Powder Inhaler Device Market Competition by Manufacturers
2.1 Global Dry Powder Inhaler Device Sales Market Share by Manufacturers (2021–2026)
2.2 Global Dry Powder Inhaler Device Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Dry Powder Inhaler Device Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Dry Powder Inhaler Device, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Dry Powder Inhaler Device, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Dry Powder Inhaler Device, Product Types and Applications
2.7 Global Key Manufacturers of Dry Powder Inhaler Device, Date of Entry into the Industry
2.8 Global Dry Powder Inhaler Device Market Competitive Situation and Trends
2.8.1 Global Dry Powder Inhaler Device Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Dry Powder Inhaler Device Players Market Share by Revenue
2.8.3 Global Dry Powder Inhaler Device Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Dry Powder Inhaler Device Market Scenario by Region
3.1 Global Dry Powder Inhaler Device Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Dry Powder Inhaler Device Sales by Region: 2021–2032
3.2.1 Global Dry Powder Inhaler Device Sales by Region: 2021–2026
3.2.2 Global Dry Powder Inhaler Device Sales by Region: 2027–2032
3.3 Global Dry Powder Inhaler Device Revenue by Region: 2021–2032
3.3.1 Global Dry Powder Inhaler Device Revenue by Region: 2021–2026
3.3.2 Global Dry Powder Inhaler Device Revenue by Region: 2027–2032
3.4 North America Dry Powder Inhaler Device Market Facts & Figures by Country
3.4.1 North America Dry Powder Inhaler Device Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Dry Powder Inhaler Device Sales by Country (2021–2032)
3.4.3 North America Dry Powder Inhaler Device Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Dry Powder Inhaler Device Market Facts & Figures by Country
3.5.1 Europe Dry Powder Inhaler Device Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Dry Powder Inhaler Device Sales by Country (2021–2032)
3.5.3 Europe Dry Powder Inhaler Device Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dry Powder Inhaler Device Market Facts & Figures by Region
3.6.1 Asia Pacific Dry Powder Inhaler Device Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Dry Powder Inhaler Device Sales by Region (2021–2032)
3.6.3 Asia Pacific Dry Powder Inhaler Device Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Dry Powder Inhaler Device Market Facts & Figures by Country
3.7.1 Latin America Dry Powder Inhaler Device Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Dry Powder Inhaler Device Sales by Country (2021–2032)
3.7.3 Latin America Dry Powder Inhaler Device Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dry Powder Inhaler Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Dry Powder Inhaler Device Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Dry Powder Inhaler Device Sales by Country (2021–2032)
3.8.3 Middle East and Africa Dry Powder Inhaler Device Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Dry Powder Inhaler Device Sales by Type (2021–2032)
4.1.1 Global Dry Powder Inhaler Device Sales by Type (2021–2026)
4.1.2 Global Dry Powder Inhaler Device Sales by Type (2027–2032)
4.1.3 Global Dry Powder Inhaler Device Sales Market Share by Type (2021–2032)
4.2 Global Dry Powder Inhaler Device Revenue by Type (2021–2032)
4.2.1 Global Dry Powder Inhaler Device Revenue by Type (2021–2026)
4.2.2 Global Dry Powder Inhaler Device Revenue by Type (2027–2032)
4.2.3 Global Dry Powder Inhaler Device Revenue Market Share by Type (2021–2032)
4.3 Global Dry Powder Inhaler Device Price by Type (2021–2032)
5 Segment by Application
5.1 Global Dry Powder Inhaler Device Sales by Application (2021–2032)
5.1.1 Global Dry Powder Inhaler Device Sales by Application (2021–2026)
5.1.2 Global Dry Powder Inhaler Device Sales by Application (2027–2032)
5.1.3 Global Dry Powder Inhaler Device Sales Market Share by Application (2021–2032)
5.2 Global Dry Powder Inhaler Device Revenue by Application (2021–2032)
5.2.1 Global Dry Powder Inhaler Device Revenue by Application (2021–2026)
5.2.2 Global Dry Powder Inhaler Device Revenue by Application (2027–2032)
5.2.3 Global Dry Powder Inhaler Device Revenue Market Share by Application (2021–2032)
5.3 Global Dry Powder Inhaler Device Price by Application (2021–2032)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Company Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Dry Powder Inhaler Device Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 GlaxoSmithKline Dry Powder Inhaler Device Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Company Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Dry Powder Inhaler Device Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 AstraZeneca Dry Powder Inhaler Device Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Company Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Dry Powder Inhaler Device Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Boehringer Ingelheim Dry Powder Inhaler Device Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Chiesi
6.4.1 Chiesi Company Information
6.4.2 Chiesi Description and Business Overview
6.4.3 Chiesi Dry Powder Inhaler Device Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Chiesi Dry Powder Inhaler Device Product Portfolio
6.4.5 Chiesi Recent Developments/Updates
6.5 Cipla
6.5.1 Cipla Company Information
6.5.2 Cipla Description and Business Overview
6.5.3 Cipla Dry Powder Inhaler Device Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Cipla Dry Powder Inhaler Device Product Portfolio
6.5.5 Cipla Recent Developments/Updates
6.6 3M
6.6.1 3M Company Information
6.6.2 3M Description and Business Overview
6.6.3 3M Dry Powder Inhaler Device Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 3M Dry Powder Inhaler Device Product Portfolio
6.6.5 3M Recent Developments/Updates
6.7 Hovione
6.7.1 Hovione Company Information
6.7.2 Hovione Description and Business Overview
6.7.3 Hovione Dry Powder Inhaler Device Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Hovione Dry Powder Inhaler Device Product Portfolio
6.7.5 Hovione Recent Developments/Updates
6.8 Mannkind
6.8.1 Mannkind Company Information
6.8.2 Mannkind Description and Business Overview
6.8.3 Mannkind Dry Powder Inhaler Device Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Mannkind Dry Powder Inhaler Device Product Portfolio
6.8.5 Mannkind Recent Developments/Updates
6.9 Mylan
6.9.1 Mylan Company Information
6.9.2 Mylan Description and Business Overview
6.9.3 Mylan Dry Powder Inhaler Device Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Mylan Dry Powder Inhaler Device Product Portfolio
6.9.5 Mylan Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Company Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Dry Powder Inhaler Device Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Novartis Dry Powder Inhaler Device Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 Schering/Merck
6.11.1 Schering/Merck Company Information
6.11.2 Schering/Merck Description and Business Overview
6.11.3 Schering/Merck Dry Powder Inhaler Device Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Schering/Merck Dry Powder Inhaler Device Product Portfolio
6.11.5 Schering/Merck Recent Developments/Updates
6.12 Teva
6.12.1 Teva Company Information
6.12.2 Teva Description and Business Overview
6.12.3 Teva Dry Powder Inhaler Device Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Teva Dry Powder Inhaler Device Product Portfolio
6.12.5 Teva Recent Developments/Updates
6.13 Vectura
6.13.1 Vectura Company Information
6.13.2 Vectura Description and Business Overview
6.13.3 Vectura Dry Powder Inhaler Device Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Vectura Dry Powder Inhaler Device Product Portfolio
6.13.5 Vectura Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dry Powder Inhaler Device Industry Chain Analysis
7.2 Dry Powder Inhaler Device Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dry Powder Inhaler Device Production Mode & Process Analysis
7.4 Dry Powder Inhaler Device Sales and Marketing
7.4.1 Dry Powder Inhaler Device Sales Channels
7.4.2 Dry Powder Inhaler Device Distributors
7.5 Dry Powder Inhaler Device Customer Analysis
8 Dry Powder Inhaler Device Market Dynamics
8.1 Dry Powder Inhaler Device Industry Trends
8.2 Dry Powder Inhaler Device Market Drivers
8.3 Dry Powder Inhaler Device Market Challenges
8.4 Dry Powder Inhaler Device Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Dry Powder Inhaler Device Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Dry Powder Inhaler Device Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Dry Powder Inhaler Device Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Dry Powder Inhaler Device Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Dry Powder Inhaler Device Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Dry Powder Inhaler Device Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Dry Powder Inhaler Device Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Dry Powder Inhaler Device Average Price (USD/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Dry Powder Inhaler Device, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Dry Powder Inhaler Device, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Dry Powder Inhaler Device, Product Types and Applications
 Table 12. Global Key Manufacturers of Dry Powder Inhaler Device, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Dry Powder Inhaler Device Companies by Tier (Tier 1, Tier 2, Tier 3), based on Dry Powder Inhaler Device Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Dry Powder Inhaler Device Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Dry Powder Inhaler Device Sales by Region (K Units), 2021–2026
 Table 18. Global Dry Powder Inhaler Device Sales Market Share by Region (2021–2026)
 Table 19. Global Dry Powder Inhaler Device Sales by Region (K Units), 2027–2032
 Table 20. Global Dry Powder Inhaler Device Sales Market Share by Region (2027–2032)
 Table 21. Global Dry Powder Inhaler Device Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Dry Powder Inhaler Device Revenue Market Share by Region (2021–2026)
 Table 23. Global Dry Powder Inhaler Device Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Dry Powder Inhaler Device Revenue Market Share by Region (2027–2032)
 Table 25. North America Dry Powder Inhaler Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Dry Powder Inhaler Device Sales by Country (K Units), 2021–2026
 Table 27. North America Dry Powder Inhaler Device Sales by Country (K Units), 2027–2032
 Table 28. North America Dry Powder Inhaler Device Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Dry Powder Inhaler Device Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Dry Powder Inhaler Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Dry Powder Inhaler Device Sales by Country (K Units), 2021–2026
 Table 32. Europe Dry Powder Inhaler Device Sales by Country (K Units), 2027–2032
 Table 33. Europe Dry Powder Inhaler Device Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Dry Powder Inhaler Device Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Dry Powder Inhaler Device Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Dry Powder Inhaler Device Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Dry Powder Inhaler Device Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Dry Powder Inhaler Device Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Dry Powder Inhaler Device Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Dry Powder Inhaler Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Dry Powder Inhaler Device Sales by Country (K Units), 2021–2026
 Table 42. Latin America Dry Powder Inhaler Device Sales by Country (K Units), 2027–2032
 Table 43. Latin America Dry Powder Inhaler Device Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Dry Powder Inhaler Device Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Dry Powder Inhaler Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Dry Powder Inhaler Device Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Dry Powder Inhaler Device Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Dry Powder Inhaler Device Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Dry Powder Inhaler Device Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Dry Powder Inhaler Device Sales (K Units) by Type (2021–2026)
 Table 51. Global Dry Powder Inhaler Device Sales (K Units) by Type (2027–2032)
 Table 52. Global Dry Powder Inhaler Device Sales Market Share by Type (2021–2026)
 Table 53. Global Dry Powder Inhaler Device Sales Market Share by Type (2027–2032)
 Table 54. Global Dry Powder Inhaler Device Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Dry Powder Inhaler Device Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Dry Powder Inhaler Device Revenue Market Share by Type (2021–2026)
 Table 57. Global Dry Powder Inhaler Device Revenue Market Share by Type (2027–2032)
 Table 58. Global Dry Powder Inhaler Device Price (USD/Unit) by Type (2021–2026)
 Table 59. Global Dry Powder Inhaler Device Price (USD/Unit) by Type (2027–2032)
 Table 60. Global Dry Powder Inhaler Device Sales (K Units) by Application (2021–2026)
 Table 61. Global Dry Powder Inhaler Device Sales (K Units) by Application (2027–2032)
 Table 62. Global Dry Powder Inhaler Device Sales Market Share by Application (2021–2026)
 Table 63. Global Dry Powder Inhaler Device Sales Market Share by Application (2027–2032)
 Table 64. Global Dry Powder Inhaler Device Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Dry Powder Inhaler Device Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Dry Powder Inhaler Device Revenue Market Share by Application (2021–2026)
 Table 67. Global Dry Powder Inhaler Device Revenue Market Share by Application (2027–2032)
 Table 68. Global Dry Powder Inhaler Device Price (USD/Unit) by Application (2021–2026)
 Table 69. Global Dry Powder Inhaler Device Price (USD/Unit) by Application (2027–2032)
 Table 70. GlaxoSmithKline Company Information
 Table 71. GlaxoSmithKline Description and Business Overview
 Table 72. GlaxoSmithKline Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 73. GlaxoSmithKline Dry Powder Inhaler Device Product
 Table 74. GlaxoSmithKline Recent Developments/Updates
 Table 75. AstraZeneca Company Information
 Table 76. AstraZeneca Description and Business Overview
 Table 77. AstraZeneca Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 78. AstraZeneca Dry Powder Inhaler Device Product
 Table 79. AstraZeneca Recent Developments/Updates
 Table 80. Boehringer Ingelheim Company Information
 Table 81. Boehringer Ingelheim Description and Business Overview
 Table 82. Boehringer Ingelheim Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 83. Boehringer Ingelheim Dry Powder Inhaler Device Product
 Table 84. Boehringer Ingelheim Recent Developments/Updates
 Table 85. Chiesi Company Information
 Table 86. Chiesi Description and Business Overview
 Table 87. Chiesi Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 88. Chiesi Dry Powder Inhaler Device Product
 Table 89. Chiesi Recent Developments/Updates
 Table 90. Cipla Company Information
 Table 91. Cipla Description and Business Overview
 Table 92. Cipla Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 93. Cipla Dry Powder Inhaler Device Product
 Table 94. Cipla Recent Developments/Updates
 Table 95. 3M Company Information
 Table 96. 3M Description and Business Overview
 Table 97. 3M Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 98. 3M Dry Powder Inhaler Device Product
 Table 99. 3M Recent Developments/Updates
 Table 100. Hovione Company Information
 Table 101. Hovione Description and Business Overview
 Table 102. Hovione Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 103. Hovione Dry Powder Inhaler Device Product
 Table 104. Hovione Recent Developments/Updates
 Table 105. Mannkind Company Information
 Table 106. Mannkind Description and Business Overview
 Table 107. Mannkind Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 108. Mannkind Dry Powder Inhaler Device Product
 Table 109. Mannkind Recent Developments/Updates
 Table 110. Mylan Company Information
 Table 111. Mylan Description and Business Overview
 Table 112. Mylan Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 113. Mylan Dry Powder Inhaler Device Product
 Table 114. Mylan Recent Developments/Updates
 Table 115. Novartis Company Information
 Table 116. Novartis Description and Business Overview
 Table 117. Novartis Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 118. Novartis Dry Powder Inhaler Device Product
 Table 119. Novartis Recent Developments/Updates
 Table 120. Schering/Merck Company Information
 Table 121. Schering/Merck Description and Business Overview
 Table 122. Schering/Merck Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 123. Schering/Merck Dry Powder Inhaler Device Product
 Table 124. Schering/Merck Recent Developments/Updates
 Table 125. Teva Company Information
 Table 126. Teva Description and Business Overview
 Table 127. Teva Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 128. Teva Dry Powder Inhaler Device Product
 Table 129. Teva Recent Developments/Updates
 Table 130. Vectura Company Information
 Table 131. Vectura Description and Business Overview
 Table 132. Vectura Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 133. Vectura Dry Powder Inhaler Device Product
 Table 134. Vectura Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Dry Powder Inhaler Device Distributors List
 Table 138. Dry Powder Inhaler Device Customers List
 Table 139. Dry Powder Inhaler Device Market Trends
 Table 140. Dry Powder Inhaler Device Market Drivers
 Table 141. Dry Powder Inhaler Device Market Challenges
 Table 142. Dry Powder Inhaler Device Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Dry Powder Inhaler Device
 Figure 2. Global Dry Powder Inhaler Device Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Dry Powder Inhaler Device Market Share by Type: 2025 & 2032
 Figure 4. Single Dose Product Picture
 Figure 5. Multi Dose Product Picture
 Figure 6. Global Dry Powder Inhaler Device Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Dry Powder Inhaler Device Market Share by Application: 2025 & 2032
 Figure 8. Asthma
 Figure 9. COPD
 Figure 10. Others
 Figure 11. Global Dry Powder Inhaler Device Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Dry Powder Inhaler Device Market Size (US$ Million), 2021–2032
 Figure 13. Global Dry Powder Inhaler Device Sales (K Units), 2021–2032
 Figure 14. Global Dry Powder Inhaler Device Average Price (USD/Unit), 2021–2032
 Figure 15. Dry Powder Inhaler Device Report Years Considered
 Figure 16. Dry Powder Inhaler Device Sales Share by Manufacturers in 2025
 Figure 17. Global Dry Powder Inhaler Device Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Dry Powder Inhaler Device Players: Market Share by Revenue in Dry Powder Inhaler Device in 2025
 Figure 19. Dry Powder Inhaler Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Dry Powder Inhaler Device Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Dry Powder Inhaler Device Sales Market Share by Country (2021–2032)
 Figure 22. North America Dry Powder Inhaler Device Revenue Market Share by Country (2021–2032)
 Figure 23. U.S. Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Dry Powder Inhaler Device Sales Market Share by Country (2021–2032)
 Figure 26. Europe Dry Powder Inhaler Device Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Dry Powder Inhaler Device Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Dry Powder Inhaler Device Revenue Market Share by Region (2021–2032)
 Figure 34. China Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Taiwan Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Indonesia Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Thailand Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Malaysia Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Philippines Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Latin America Dry Powder Inhaler Device Sales Market Share by Country (2021–2032)
 Figure 45. Latin America Dry Powder Inhaler Device Revenue Market Share by Country (2021–2032)
 Figure 46. Mexico Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Brazil Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Argentina Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Middle East and Africa Dry Powder Inhaler Device Sales Market Share by Country (2021–2032)
 Figure 50. Middle East and Africa Dry Powder Inhaler Device Revenue Market Share by Country (2021–2032)
 Figure 51. Turkey Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Saudi Arabia Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. U.A.E Dry Powder Inhaler Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Global Sales Market Share of Dry Powder Inhaler Device by Type (2021–2032)
 Figure 55. Global Revenue Market Share of Dry Powder Inhaler Device by Type (2021–2032)
 Figure 56. Global Dry Powder Inhaler Device Price (USD/Unit) by Type (2021–2032)
 Figure 57. Global Sales Market Share of Dry Powder Inhaler Device by Application (2021–2032)
 Figure 58. Global Revenue Market Share of Dry Powder Inhaler Device by Application (2021–2032)
 Figure 59. Global Dry Powder Inhaler Device Price (USD/Unit) by Application (2021–2032)
 Figure 60. Dry Powder Inhaler Device Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc